Discounted Cash Flow
Cellebrite DI Ltd. Foreign
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2019 | $171.9m | $-1.9m | $9.9m | -1.1% | $0.19 |
| 2020 | $194.9m (13.4%) | $5.8m (408.2%) | $5.8m (-41.7%) | 3.0% (371.7%) | $-0.62 (-431.1%) |
| 2021 | $246.2m (26.3%) | $71.4m (1135.0%) | $30.9m (435.2%) | 29.0% (877.6%) | $1.01 (263.8%) |
| 2022 | $270.7m (9.9%) | $120.8m (69.2%) | $13.7m (-55.8%) | 44.6% (53.9%) | $1.04 (2.6%) |
| 2023 | $325.1m (20.1%) | $-81.1m (-167.1%) | $96.8m (607.8%) | -24.9% (-155.9%) | $1.00 (-3.9%) |
| 2024 | $401.2m (23.4%) | $-283.0m (-249.0%) | $123.6m (27.7%) | -70.5% (-182.8%) | $1.00 (0.0%) |
| 2025 | $475.7m (18.6%) | $78.3m (127.7%) | $160.3m (29.7%) | 16.5% (123.3%) | $1.01 (0.7%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.